Evidence map›Paper›PMID 33524166›Full record

ArticleCancer2021

Clinical and organizational risk factors for mortality during deterioration events among pediatric oncology patients in Latin America: A multicenter prospective cohort.

Asya Agulnik, Adolfo Cárdenas, Angela K Carrillo, Purva Bulsara, Marcela Garza, Yvania Alfonso Carreras, Manuel Alvarado, Patricia Calderón, Rosdali Díaz, Claudia de León and 14 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Oncology Education in Latin America: A Systematic Review of Curricular Gaps, Teaching Strategies, and Regional Initiatives.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Collaboration for success: the Global Initiative for Childhood Cancer in Latin America.Revista panamericana de salud publica = Pan American journal of public health · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 14 institutions in 9 countries.

Asya AgulnikDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-8932-8181
Adolfo CárdenasCritical Care Medicine, Hospital Infantil Teletón de Oncología, Queretaro, Mexico.
Angela K CarrilloDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.
Purva BulsaraDepartment of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee.
Marcela GarzaDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.
Yvania Alfonso CarrerasPediatric Oncology, Hospital Saint-Damien, Port-Au-Prince, Haiti.
Manuel AlvaradoCritical Care, Hospital del Niño Dr. José Renán Esquivel, Panama City, Panama.
Patricia CalderónOncology, Hospital Infantil Manuel de Jesús Rivera, Managua, Nicaragua.
Rosdali DíazPediatric Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Claudia de LeónPediatric Critical Care, Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala.
Claudia Del RealPediatric Oncology, Benemérito Hospital General con Especialidades ¨Juan María de Salvatierra", La Paz, Mexico.
Tania HuitzPediatric Oncology, Centro Estatal de Oncología de Campeche, Campeche, Mexico.
Angélica MartínezPediatric Oncology, Hospital General de Tijuana, Tijuana, Mexico.
Scheybi MiraldaPediatric Critical Care, Hospital Escuela Universitario, Tegucigalpa, Honduras.
Erika MontalvoPediatric Critical Care, Sociedad de Lucha contra el Cáncer Núcleo de Quito, Quito, Ecuador.
Octavia NegrínHematology, Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo, Dominican Republic.
Alejandra OsunaHematology/Oncology, Hospital Pediátrico de Sinaloa, Sinaloa, Mexico.
Clara Krystal Perez FerminHematology/Oncology, Hospital Infantil Regional Universitario Dr. Arturo Guillón, Santiago, Dominican Republic.
Estuardo PinedaOncology, Hospital Nacional de Niños Benjamín Bloom, San Salvador, El Salvador.
Dora SoberanisHematology/Oncology, Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala.
Maria Susana Juárez TobiasPediatric Critical Care, Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, Mexico.
Zhaohua LuDepartment of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee.
Carlos Rodriguez-GalindoDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee.
EVAT Study Group
St. Jude Children's Research Hospital · USHospital Infantil Dr. Robert Reid Cabral · DOAutonomous University of Campeche · MXBenemerito Hospital General con Especialidades "Juan Maria de Salvatierra" · MXGheskio Centers · HTHospital Central Dr. Ignacio Morones Prieto · MXHospital del Niño · PAHospital Infantil Manuel de Jesús Rivera · NIHospital Nacional de Niños Bloom · SVInstituto Nacional de Enfermedades Neoplásicas · PEInstituto Tecnológico de Querétaro · MXPediatric Hospital of Sinaloa · MXUniversidad de Tijuana · MXUniversidad Metropolitana de Honduras · HN

Funding

American Lebanese Syrian Associated Charities (ALSAC)Conquer Cancer Foundation Global Oncology Young Investigator Award
6 · The paper itself

Abstract

backgroundHospitalized pediatric hematology-oncology (PHO) patients have frequent clinical deterioration events (CDE) requiring intensive care unit (ICU) admission, particularly in resource-limited settings. The objective of this study was to describe CDEs in hospitalized PHO patients in Latin America and to identify event-level and center-level risk factors for mortality.

methodsIn 2017, the authors implemented a prospective registry of CDEs, defined as unplanned transfers to a higher level of care, use of ICU-level interventions on the floor, or nonpalliative floor deaths, in 16 PHO centers in 10 countries. PHO hospital admissions and hospital inpatient days were also reported. This study analyzes the first year of registry data (June 2017 to May 2018).

resultsAmong 16 centers, 553 CDEs were reported in PHO patients during 11,536 admissions and 119,414 inpatient days (4.63 per 1000 inpatient days). Event mortality was 29% (1.33 per 1000 inpatient days) but ranged widely across centers (11%-79% or 0.36-5.80 per 1000 inpatient days). Significant risk factors for event mortality included requiring any ICU-level intervention on the floor and not being transferred to a higher level of care. Events with organ dysfunction, a higher severity of illness, and a requirement for ICU intervention had higher mortality. In center-level analysis, hospitals with a higher volume of PHO patients, less floor use of ICU intervention, lower severity of illness on transfer, and lower rates of floor cardiopulmonary arrest had lower event mortality.

conclusionsHospitalized PHO patients who experience CDEs in resource-limited settings frequently require floor-based ICU interventions and have high mortality. Modifiable hospital practices around the escalation of care for these high-risk patients may contribute to poor outcomes. Earlier recognition of critical illness and timely ICU transfer may improve survival in hospitalized children with cancer.

Indexed as

Clinical DeteriorationIntensive Care Units, PediatricNeoplasmsChildHospitalizationHumansLatin AmericaProspective StudiesRisk Factorsclinical deteriorationintensive careLatin AmericaPediatric Early Warning Systems (PEWS)pediatric oncologyresource-limited settings

Identifiers

PMID33524166
PMCPMC8248122
OpenAlexW3128623258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.